Luckystar Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -98.04%
(FY 2022)
- Profit -72.44%
(FY 2022)
- Ebitda -103.75%
(FY 2022)
- Net Worth 4.20%
(FY 2022)
- Total Assets 3.73%
(FY 2022)
About Luckystar Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nirav Shah, Devina Shah, Jayesh Pancholi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U51909MH2017PTC294353
- Company No.
294353
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 2017
- Date of AGM
23 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Luckystar Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirav Shah  | Director | 26-Apr-2017 | Current |
| Karl Surty | Director | 20-Jul-2020 | Current |
| Devina Shah | Director | 01-Sep-2021 | Current |
| Jayesh Pancholi | Director | 10-Feb-2020 | Current |
| Himanshu Trivedi | Director | 10-Feb-2020 | Current |
Financial Performance of Luckystar Pharma.
Luckystar Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 98.04% decrease. The company also saw a substantial fall in profitability, with a 72.44% decrease in profit. The company's net worth moved up by a moderate rise of 4.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Luckystar Pharma?
In 2019, Luckystar Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Express Pharma LimitedActive 19 years 10 months
Nirav Shah, Devina Shah and 2 more are mutual person
- Speedking Pharma Private LimitedActive 19 years 9 months
Nirav Shah, Devina Shah and 2 more are mutual person
- Celebrate Services Private LimitedActive 29 years 6 months
Nirav Shah and Devina Shah are mutual person
- Sevenstar Realtek Private LimitedActive 67 years 8 months
Nirav Shah and Devina Shah are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Luckystar Pharma?
Luckystar Pharma has a workforce of 48 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Luckystar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Luckystar Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
